These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2533081)

  • 1. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.
    Gozlan H; Schechter LE; Bolanos F; Emerit MB; Miquel MC; Nielsen M; Hamon M
    Eur J Pharmacol; 1989 Dec; 172(6):497-500. PubMed ID: 2533081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
    Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
    Emerit MB; Gozlan H; Marquet A; Hamon M
    Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
    Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
    Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM; Barnes NM
    Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM; Costall B; Naylor RJ
    J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells.
    Idres S; Delarue C; Lefebvre H; Vaudry H
    Brain Res Mol Brain Res; 1991 Jun; 10(3):251-8. PubMed ID: 1653392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
    Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
    Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
    Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
    Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 5-hydroxytryptamine 1A-like binding sites in human ganglioneuroblastoma.
    Pranzatelli MR; Balletti J
    Neurosci Lett; 1991 Oct; 132(1):117-20. PubMed ID: 1838579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain.
    Pandey SC; Isaac L; Davis JM; Pandey GN
    Eur J Pharmacol; 1991 Sep; 202(2):221-5. PubMed ID: 1839385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
    Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
    J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex.
    Fuxe K; von Euler G; Agnati LF; Ogren SO
    Neurosci Lett; 1988 Feb; 85(1):163-7. PubMed ID: 2452385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
    Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
    Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H
    Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and serotonin binding site studies of some conformationally restricted indolylethylamine analogues based on 2-amino-3-(3'-indolyl)bicyclo[2.2.2]octane.
    Schlecht MF; Tsarouhtsis D; Lipovac MN; Debler EA
    J Med Chem; 1990 Jan; 33(1):386-94. PubMed ID: 2136918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.